Enter your keywords
HOME
About Us
NEWSLETTER
To search AlzRisk, use the "Keyword" search on the
AlzRisk search page
.
NEWS
All News
Conference Coverage
Series
WEBINARS
All Webinars
Databases
AlzBiomarker
AlzPedia
AlzRisk
Antibodies
Genetics
AlzGene
HEX
Mutations
Protocols
Research Models
Therapeutics
PAPERS
All Papers
Papers of the Week
Milestone
Alzforum Recommends
PROFESSIONAL RESOURCES
Conference Calendar
Grants
Jobs
Member Directory
ABOUT AD
AD Overview
Early-Onset Familial
The HBO Alzheimer's Project
Supported Browsers
MY ALZFORUM
My AlzForum Home
View Library
View Notifications
Set Notifications
Edit Profile
AlzRisk Paper Detail
Risk Factors
Alcohol
B Vitamins
Blood Pressure
Cognitive Activity
Diabetes Mellitus
Dietary Pattern
Head injury
Homocysteine
Hormone Therapy
Inflammatory Biomarkers
Non-Steroidal Anti-Inflammatory Drugs
Nutritional Antioxidants
Obesity
Physical Activity
Statin use
Reference:
Hooshmand, 2010
Cohort:
North Karelia Project/FINMONICA/Cardiovascular Risk Factors, Aging, and Dementia
Risk Factor:
B Vitamins
Exposure Detail
Venous blood samples were taken at baseline and serum specimens were stored at or below 20°C. Serum folate was measured by a chemiluminescent microparticle folate binding protein assay. The interassay coefficients of variation (CV) for folate 13% and 11% at the levels of 7.5 and 31 nM/L, respectively.
Ethnicity Detail
Participants included residents residing in the areas of Kuopio and Joensuu, Finland. No other information was provided on the race or ethnicity of the participants.
Screening and Diagnosis Detail
Screening Method:
MMSE
Mini-Mental State Examination (Folstein 1975)
AD Diagnosis:
NINCDS ADRDA
National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association Criteria (McKhann 1984)
Total dementia definition
: Dementia via DSM-IV.
"Cognitive impairment and dementia were identified in 3 phases: screening phase, clinical phase, and differential diagnosis phase. In the screening phase, subjects who scored 24 in the Mini-Mental State Examination (MMSE) [18], had a decline of 3 points in MMSE since the 1998 reexamination, or
had a delayed recall in Consortium to Establish a Registry for
Alzheimer’s Disease word list[19] of 70%, or for whom there was
serious informant concern regarding the participant’s cognition,
were referred for thorough neurologic, cardiovascular, and detailed neuropsychologic examinations (the clinical phase). A review board consisting of the study physician, the study neuropsychologist, and a senior neurologist ascertained the primary diagnosis based on all available information. Subjects with possible dementia were invited to the differential diagnosis phase, which included brain imaging, CSF analysis, EKG, and blood tests. All data accumulated from the screening and clinical phases were carefully reanalyzed by the review board before establishing the final diagnosis. Dementia was diagnosed according to DSM-IV criteria [20], and AD was diagnosed according to the US National Institute of Neurologic and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association criteria[21]."
Covariates & Analysis Detail
Analysis Type:
Logistic regression
"Analyses were adjusted for baseline age, sex, years of full-time education, and follow-up time (model 1), and then additionally for other potential confounding or mediating factors, including APOE ϵ4 status, baseline BMI, SBP, DBP, MMSE score, history of stroke, and smoking (model 2). All variables were entered as continuous into the models except sex, APOE ϵ4, history of stroke, and smoking, which were dichotomized."
AD Covariates:
A
age
E
education
G
gender
APOE4
APOE e4 genotype
MMSE
baseline MMSE
BMI
body mass index
DBP
diastolic blood pressure
FUT
follow up time
SM
smoking status
SH
stroke history
SBP
systolic blood pressure